Mass-spectrometric analysis of APOB polymorphism rs1042031 (G/T) and its influence on serum proteome of coronary artery disease patients: genetic-derived proteomics consequences-Reference-Cited by-同舟云学术

Mass-spectrometric analysis of APOB polymorphism rs1042031 (G/T) and its influence on serum proteome of coronary artery disease patients: genetic-derived proteomics consequences

Published:2023-07-06 Issue: Volume: Page:
ISSN:0300-8177
Container-title:Molecular and Cellular Biochemistry
language:en
Short-container-title:Mol Cell Biochem

Author:

Zafar Muneeza,Malik Imran Riaz,Mirza Munazza Raza,Awan Fazli Rabbi,Nawrocki Arkadiusz,Hussain Misbah,Khan Haq Nawaz,Abbas Shahid,Choudhary Muhammad Iqbal,Larsen Martin R.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11010-023-04797-x.pdf

Reference62 articles.

1. Coremans C, Delporte C, Cotton F, Van De Borne P, Boudjeltia KZ, Van Antwerpen P (2021) Mass spectrometry for the monitoring of lipoprotein oxidations by myeloperoxidase in cardiovascular diseases. Molecules 26(17):5264

2. Marczak L, Idkowiak J, Tracz J, Stobiecki M, Perek B, Kostka-Jeziorny K, Luczak M (2021) Mass spectrometry-based lipidomics reveals differential changes in the accumulated lipid classes in chronic kidney disease. Metabolites 11(5):275

3. Ang YM, Low YY, Lee YP, Nazarie FW, Guryev V, Jamal R (2019) ‘‘Proteogenomics: From next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine. Clin Chim Acta 498:38–46

4. Masson W (2020) Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: A meta-analysis and meta-regression. Lipids Health Dis 19:1–11

5. Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, Murray C (2017) Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. Am J Card 70(1):1–25